athenahealth to Acquire Mobile Health Leader Epocrates Acquisition will accelerate athenahealth’s vision to build the nation’s health information backbone; companies will combine forces to redefine physician mobile experience and point-of-care toolset San Mateo, CA...
Pearl Therapeutics Strengthens Its Organization by Hiring Dr. Michael Riebe, an Industry Veteran in Respiratory Product Development REDWOOD CITY, CALIF., January 17, 2013 – Pearl Therapeutics Inc. today announced that Michael Riebe, Ph.D. has joined Pearl...
Oxford Immunotec and Lophius Biosciences sign licensing and collaboration agreements Oxford, UK; January 29th, 2013 – Oxford Immunotec, a medical diagnostic company developing tests in the fields of infectious and immunological disease and Lophius Biosciences, a...
Relypsa Enrolls Initial Patient in Pivotal Phase 3 Program for the Treatment of Hyperkalemia Redwood City, CA, February 20, 2013 – Relypsa, Inc., a clinical-stage biopharmaceutical company, announced that he first patient has been enrolled in the company’s pivotal...
NxStage Announces CE Mark Approval, First Clinical Use of its Single Needle for Dialysis Patients Elegant Solution Enhances Company’s Recent Nocturnal Clearance in Europe LAWRENCE, Mass., Feb. 25, 2013 /PRNewswire/ — NxStage® Medical, Inc. (Nasdaq: NXTM),...
Recent Comments